Researchers develop low-cost electroporation device that could expand global access to cancer drugs

SUTD researchers develop low-cost electroporation device that could expand global access to cancer drugs
Schematic of the process of pore formation in phospholipid bilayer after electroporation. Credit: SUTD

Researchers from the Singapore University of Technology and Design (SUTD) have developed a microsize-gap multiple-shot electroporation (M2E) device that could improve the effectiveness of delivering cancer drugs at a lower cost, globally.

“One of the goals of the scientific community is to develop a method for cancer drug delivery that is simple, manufacturable and low-cost,” said Desmond Loke, an assistant professor at SUTD and principal investigator of this research.

A way to enhance prospects for cancer drug delivery may be through electroporation—a method in which a very weak electric pulse is applied to cells to temporarily open holes in their membranes. The cancer medicines can be sent in through these holes. The application of electroporation together with cancer drugs could enhance both drug effectiveness and accessibility.

The researchers integrated into the device to enhance visualization of cancer drugs. “The narrow gap between electrodes allow us to achieve sufficiently strong electric field using a few volts rather than several tens of volts applied in traditional electroporation,” said Assistant Prof Loke. This low voltage, plus electrode transparency, minimize and facilitate visibility, which help avoid unsafe usage of the drugs and limited imaging of drug transport during drug testing–both of which are common problems of traditional electroporation systems.

Additionally, in electrochemotherapy applications, tumor cells can be permeabilized by electroporation, thereby enhancing their uptake of chemotherapeutic drugs such as bleomycin and cisplatin.

The researchers tested the M2E device using cancer-drug-related molecules. The device allows cancer cells to show a for the uptake of molecules of 2 hours, which is 400% larger than conventional electroporation systems. Furthermore, it is reusable. The researchers suggest that the M2E system could work with associated drugs for treating Covid-19 as well.

“The device developed by SUTD doesn’t require specialized components, expensive materials or a complicated fabrication process, unlike traditional machines,” Assistant Prof Loke noted.

Optimisations of the M2E system are currently underway and researchers expect that it could take a few years for the device to complete clinical study and be ready for wider use. “We hope the M2E system could provide a path to significantly improve the delivery process and allow a more uniform distribution of to under-resourced and underserved regions worldwide,” added Assistant Prof Loke.

The research was published in ACS Omega.



More information:
Denise Lee et al, Ultralong-Time Recovery and Low-Voltage Electroporation for Biological Cell Monitoring Enabled by a Microsized Multipulse Framework, ACS Omega (2021). DOI: 10.1021/acsomega.1c04257

Citation:
Researchers develop low-cost electroporation device that could expand global access to cancer drugs (2022, February 11)
retrieved 20 February 2022
from https://phys.org/news/2022-02-low-cost-electroporation-device-global-access.html

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no
part may be reproduced without the written permission. The content is provided for information purposes only.

Note: This article have been indexed to our site. We do not claim legitimacy, ownership or copyright of any of the content above. To see the article at original source Click Here

Related Posts
Dangerous Flu Comeback Expected atop COVID This Winter thumbnail

Dangerous Flu Comeback Expected atop COVID This Winter

A feared “twindemic” of influenza and COVID never came to pass last year, but the outlook for such a confluence this winter is resurfacing similar concerns among epidemiologists and other infectious disease experts. Flu cases started to tick up in October and November, and those months saw an outbreak at the University of Michigan at…
Read More
Readers Respond to the October 2023 Issue thumbnail

Readers Respond to the October 2023 Issue

February 1, 20245 min readLetters to the editors for the October 2023 issue of Scientific American Credit: Scientific American, October 2023RESIDENTIAL SPACE?I was astounded by the challenges to leaving Earth detailed by Sarah Scoles in “Why We'll Never Live in Space.” I could only conclude that we will never achieve this goal. But then I visualized
Read More
We Asked a NASA Scientist: What’s the Difference Between Asteroids, Comets and Meteors? [Video] thumbnail

We Asked a NASA Scientist: What’s the Difference Between Asteroids, Comets and Meteors? [Video]

What’s the difference between asteroids, comets and meteors? These space rocks each have their own unique attributes. But differences aside, these fascinating objects are all worthy of study. Just ask NASA JPL scientist Ryan Park and he’ll agree. Well, they’re all planetary objects orbiting the Sun. An asteroid is a small, rocky object and when…
Read More
Earth’s Safe Planetary Boundary for Pollutants – Including Plastics – Exceeded thumbnail

Earth’s Safe Planetary Boundary for Pollutants – Including Plastics – Exceeded

The updated Planetary Boundaries framework (2022) showing 5 boundaries transgressed, now including “novel entities.” Credit: Stockholm Resilience Centre/Azote First assessment published of planetary boundary related to “novel entities.” For the first time, an international team of researchers has assessed the impact on the stability of the Earth system of the cocktail of synthetic chemicals and…
Read More
Index Of News
Consider making some contribution to keep us going. We are donation based team who works to bring the best content to the readers. Every donation matters.
Donate Now

Subscription Form

Liking our Index Of News so far? Would you like to subscribe to receive news updates daily?

Total
0
Share